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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of vitamin K3 (menadione 
sodium bisulphite and menadione nicotinamide bisulphite) as a feed 
additive for all animal species
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Vitamin K describes a group of lipophilic vitamins that exist naturally in two forms: vitamin K1 (phylloquinone, 
found  in  green  plants)  and  vitamin  K2  (a  group  of  menaquinones  synthesised  by  bacteria  in  the  intestine). 
Vitamin K3 (or menadione) is a synthetic form of vitamin K without a side chain. To become active, menadione 
needs to undergo prenylation. Vitamins K1, K2 and K3 are metabolically activated in the liver to become co-
factors in the activation of vitamin K-dependent proteins, which are important for normal blood coagulation, and 
normality of bones and arteries (Gla proteins). Acute toxicity of menadione or its derivatives is reached at levels 
exceeding the requirements by a factor of at least 1 000. Menadione sodium bisulphite (MSB) and menadione 
nicotinamide bisulphite (MNB) are safe for all animal species at practical use levels in feed. The use of MSB in 
water for drinking is likely to increase the exposure of target animals to chromium(VI). Therefore, the FEEDAP 
Panel has concerns about the safety of MSB when administered by this route. The use of MSB and MNB in 
animal nutrition does not give rise to safety concerns for consumers. MSB is an eye irritant; in the absence of 
adequate data, the additive should be considered as a skin sensitiser. In the absence of data, MNB should be 
considered as irritant to skin and eyes and as a skin sensitiser. Considering the high dusting potential of MSB 
and MNB, the absence of data on inhalation toxicity and the chromium(VI) content of dust, inhalation exposure 
resulting from handling of MSB and MNB could be hazardous. The use of MSB and MNB in animal nutrition 
does not pose a risk to the environment. MSB and MNB are regarded as effective sources of vitamin K in animal 
nutrition.  
© European Food Safety Authority, 2014 
KEY WORDS 
nutritional  additive,  vitamins  and  pro-vitamins,  vitamin  K3,  menadione  sodium  bisulphite,  menadione 
nicotinamide bisulphite, safety 
                                                       
1  On request from the European Commission, Question No EFSA-Q-2012-00111, adopted on 5 December 2013. 
2  Panel  members:  Gabriele  Aquilina,  Vasileios  Bampidis,  Maria  De  Lourdes  Bastos,  Lucio  Guido  Costa,  Gerhard 
Flachowsky, Mikolaj Antoni Gralak, Christer Hogstrand, Lubomir Leng, Secundino López-Puente, Giovanna Martelli, 
Baltasar Mayo, Fernando Ramos, Derek Renshaw, Guido Rychen, Maria Saarela, Kristen Sejrsen, Patrick Van Beelen, 
Robert John Wallace and Johannes Westendorf. Correspondence: FEEDAP@efsa.europa.eu 
3  Acknowledgement: The Panel wishes to thank the members of the Working Group on Vitamins,  including Jürgen Gropp, 
Georges Bories and Alberto Mantovani, for the preparatory work on this scientific opinion.  
 Vitamin K3 for all animal species 
 
EFSA Journal 2014;12(1):3532  2 
SUMMARY 
Following a request from European Commission, the Panel on Additives and Products or Substances 
used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and efficacy of 
vitamin K3 in the form of menadione sodium bisulphite and menadione nicotinamide bisulphite as a 
nutritional  additive  for  all  animal  species.  Menadione  sodium  bisulphite  (MSB)  and  menadione 
nicotinamide bisulphite (MNB) are intended for addition to feed. MSB is also intended for use in 
water for drinking. 
Vitamin K describes a group of lipophilic vitamins that exist naturally in two forms: vitamin K1 
(phylloquinone,  found  in  green  plants)  and  vitamin  K2  (a  group  of  menaquinones  synthesised  by 
bacteria in the intestine). Vitamin K3 (or menadione) is a synthetic form of vitamin K without a side 
chain.  To  become  active,  menadione  needs  to  undergo  prenylation.  Vitamins  K1,  K2  and  K3  are 
metabolically activated in the liver to become co-factors in the activation of vitamin K-dependent 
proteins, which are important for normal blood coagulation, and normality of bones and arteries (Gla 
proteins). 
Acute toxicity of menadione or its derivatives is reached at levels exceeding the requirements by a 
factor of at least 1 000. MSB and MNB are safe for all animal species at practical use levels in feed. 
The  use  of  MSB  in  water  for  drinking  is  likely  to  increase  the  exposure  of  target  animals  to 
chromium(VI).  Therefore,  the  FEEDAP  Panel  has  concerns  about  the  safety  of  MSB  when 
administered by this route. 
The use of MSB and MNB in animal nutrition does not give rise to safety concerns for consumers. 
MSB is an eye irritant; in the absence of adequate data, the additive should be considered as a skin 
sensitiser. In the absence of data, MNB should be considered as irritant to skin and eyes and as a skin 
sensitiser. Considering the high dusting potential of MSB and MNB, the absence of data on inhalation 
toxicity and the chromium(VI) content of dust, inhalation exposure from handling of MSB and MNB 
could be hazardous. 
The use of MSB and MNB in animal nutrition does not pose a risk to the environment. 
MSB and MNB are regarded as effective sources of vitamin K in animal nutrition. 
The  FEEDAP  Panel  made  some  recommendations  on  (i)  the  labelling  of  the  additives,  (ii)  the 
reduction of the content of hexavalent chromium, (iii) the storage of vitamin mineral premixtures 
containing MSB, and (iv) the restricted distribution of the pure substances on the market.  Vitamin K3 for all animal species 
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an 
application in accordance with Article 7;  in addition, Article 10(2) of that Regulation also specifies 
that for existing products within the meaning of Article 10(1), an applica tion shall be submitted in 
accordance with Article 7, at the latest one year before the expiry date of the authorisation given 
pursuant to Directive 70/524/EEC for additives with a limited authorisation period, and within a 
maximum of seven years after the entry into force of this Regulation for additives authorised without a 
time limit or pursuant to Directive 82/471/EEC. 
The  European  Commission  received  a  request  from  VITAC  EEIG  Vitamins  Authorisation 
Consortium
5 for authorisation of a new use (i.e. use in water for drinking) of vitamin K3 in the form of 
menadione  sodium  bisulphite  and  re-evaluation  of  authorisation  of  vitamin  K3  in  the  form  of 
menadione sodium bisulphite and menadione nicotinamide bisulphite when used as a feed additive for 
target  species  (nutritional  additive;  functional  group:  vitamins,  pro-vitamins  and  chemically  well-
defined substances having similar effect) under the conditions mentioned in Tables 1 and 2.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive) and under Article 10(2) (re-evaluation 
of an authorised feed additive). EFSA received directly from the applicant the technical dossier in 
support of this application.
6 According to Article 8 of that Regulation, EFSA, after verifying the 
particulars and documents submitted by the applicant, shall undertake an assessment in order to 
determine  whether the feed additive complies with the conditions laid down in Article 5. The 
particulars and documents in support of the application were considered valid by EFSA as of  22 
February 2012.
7 
Vitamin K has been authorised without time limit under Council Directive 70/524/EEC
8 for its use for 
all animal species as a nutritional additive. 
The Scientific Committee on Food expressed an opinion on the tolerable upper intake level of vitamin 
K (EC, 2003). The Scientific Committee for Veterinary Medicinal Produ cts expressed an opinion on 
phytomenadione (vitamin K1) and menadione (vitamin K3) (EMEA, 1998). The EFSA Panel on Food 
Additives and Nutrient Sources added to Food (ANS) issued an opinion on the inability to assess the 
safety  of  vitamin  K-enriched  yeast  for  nutritional  purposes  as  a  source  of  vitamin  K  in  food 
supplements and the bioavailability of vitamin K from this source, based on the supporting dossier 
(EFSA, 2009a). The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) expressed one 
opinion on the safety of vitamin K2 (EFSA, 2008) and three opinions on the substantiation of several 
health claims pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (EFSA NDA Panel, 2009, 
2011, 2012). 
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5   On 13/03/2013, EFSA was informed by the applicant that VITAC EEIG was liquidated on 19/12/2012 and their rights as 
applicant were transferred to FEFANA asbl (EU Association of Specialty Feed Ingredients and their Mixtures, representing 
notably  the  following  companies:  Lohmann  Animal  Health  GmbH &  Co  KG,  Cuxhaven,  Germany;  Trouw  Nutrition 
International BV, Putten, the Netherlands). Avenue Louise, 130A, Box 1, 1050 Brussels, Belgium. 
6   EFSA Dossier reference: FAD-2010-0099. 
7  A new mandate was received in EFSA in January 2012. 
8  Commission List of the authorised additives in feedingstuffs published in application of Article 9t (b) of Council Directive 
70/524/EEC concerning additives in feedingstuffs (2004/C 50/01). OJ C 50, 25.2.2004, p. 1. Vitamin K3 for all animal species 
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safety for the target animals, consumer, user and the environment and the efficacy of vitamin K3 in the 
form of menadione sodium bisulphite and menadione nicotinamide bisulphite, when used under the 
conditions described in Tables 1 and 2. Vitamin K3 for all animal species 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Vitamin K3 – Menadione Sodium Bisulphite (MSB) 
Registration  number/EC 
No/No  
Not appropriate 
Category of additive  3. Nutritional Additives 
Functional group(s) of additive  (a) Vitamins, pro-vitamins and chemically well-defined substances having 
similar effect 
 
Description 
Composition, description  Chemical formula  Purity criteria  Method of analysis 
Menadione Sodium Bisulphite 
1,2,3,4-Tetrahydro-2-
methyl-1,4-dioxo-2-
naphthalenesulfonic 
acid, sodium salt, 
trihydrate 
CAS No.: 6147-37-1 
Minimum 50 % 
Menadione, which 
represents at least 
96% Menadione 
sodium bisulphite 
trihydrate complex 
Photometric method 
(VDLUFA Bd. III, 
13.7.1) 
 
Trade name   Not appropriate 
Name  of  the  holder  of 
authorisation  
Not appropriate 
 
Conditions of use 
Species  or 
category of animal 
Maximum 
age 
Minimum content  Maximum content 
Withdrawal period  mg/kg  of  complete  feedingstuffs,  supplementary 
feed (based on end feed) and in water* 
All animal species 
and categories 
No 
restrictions 
- during all 
life cycle  
-  -  - 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions for 
use  
Additive has to be incorporated in premixture. Directly dosage to 
mixed feed is not recommended. 
Specific conditions or restrictions for 
handling 
Handle  in  accordance  with  good  industrial  hygiene  and  safety 
practice. 
Post market monitoring   Not appropriate 
Specific  conditions  for  use  in 
complementary feedingstuffs or water  Not appropriate 
 
Maximum Residue Limit (MRL)  
Marker residue  Species or category of 
animal  Marker residue  Species or category of 
animal 
Not appropriate  Not appropriate  Not appropriate  Not appropriate Vitamin K3 for all animal species 
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Table 2:   Description and conditions of use of the additive as proposed by the applicant  
Additive   Vitamin K3 – Menadione Nicotinamide Bisulphite (MNB) 
Registration  number/EC 
No/No  
Not appropriate 
Category of additive  3. Nutritional Additives  
Functional group(s) of additive 
(a) Vitamins, pro-vitamins and chemically well-defined substances having 
similar effect 
 
Description 
Composition, description  Chemical formula  Purity criteria  Method of analysis 
Menadione Nicotinamide 
Bisulphite 
1,2,3,4-Tetrahydro-2-
methyl-1,4-
dioxonapthalen-2-
naphthalenesulfonic 
acid compound with 3-
Pyridinecarboxamide 
CAS No.: 73581-79-0 
Minimum 44% 
Menadione, which 
represents at least 
96% Menadione 
nicotinamide 
bisulphite complex 
Photometric method 
(VDLUFA Bd. III, 
13.7.1) 
 
Trade name   Not appropriate 
Name  of  the  holder  of 
authorisation  
Not appropriate 
 
Conditions of use 
Species  or 
category  of 
animal 
Maximum 
age 
Minimum content  Maximum content  Withdrawal 
period  mg/kg complete feedingstuffs, supplementary 
feed (based on end feed) and in water* 
All  animal 
species  and 
categories 
No 
restriction
s  -  during 
all  life 
cycle 
-  -  - 
 
Other provisions and additional requirements for the labelling 
Specific conditions or restrictions  for 
use  
Additive has to be incorporated in premixture. Directly dosage to 
mixed feed is not recommended.  
Specific conditions or restrictions  for 
handling  
Handle  in  accordance  with  good  industrial  hygiene  and  safety 
practice. 
Post market monitoring   Not appropriate 
Specific  conditions  for  use  in 
complementary feedingstuffs or water  Not appropriate 
 
Maximum Residue Limit (MRL) 
Marker residue  Species or category of 
animal  Marker residue  Species or category of 
animal 
Not appropriate  Not appropriate  Not appropriate  Not appropriate Vitamin K3 for all animal species 
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ASSESSMENT 
This  opinion  is  based  in  part  on  data  provided  by  a  consortium  of  companies  involved  in  the 
production/distribution  of  vitamin  K3  in  the  form  of  menadione  sodium  bisulphite  (MSB)  and 
menadione  nicotinamide  bisulphite  (MNB).  It  should  be  recognised  that  these  data  cover  only  a 
fraction of existing additives containing vitamin K3 in the form of MSB and MNB. The application is 
for the active substance and the composition of the additive formulations is not the subject of the 
application. The Panel has sought to use the data provided together with data from other sources to 
deliver an opinion. 
The application contains data from two sources each of MSB and MNB, both obtained by chemical 
synthesis. 
1.  Introduction 
Vitamin K describes a group of lipophilic vitamins that exist naturally in two forms: vitamin K1 is 
phylloquinone (also called phytomenadione or phytonadione), which is found in green plants, and 
vitamin K2  is a group of menaquinones which are synthesised by bacteria in the intestine. These 
compounds contain a common 2-methyl-1,4-naphthoquinone ring structure but differ from each other 
in  the  length  and  saturation  degree  of  the  polyisopropenoid  side  chain  attached  at  position  3. 
Phylloquinone  has  a  phytyl  substituent  (four  isoprenic  units,  one  of  which  is  unsaturated). 
Menaquinones (MK) have side chains composed of a variable number (n) of prenyl units, designated 
as  MK-n.  Vitamin  K3  (or  menadione) is  a  synthetic  form  without  side  chain.  To  become  active, 
menadione must undergo prenylation. Menadione release occurs in the intestine, its prenylation into 
MK-4 occurring in the intestine and tissues. Lipophilicity varies according to the number of isoprenic 
units, impacting on the different functions of intestinal absorption, transport, bioavailability and tissue 
distribution.  
Vitamins K1, K2 and K3 are metabolically activated in the liver to become co-factors in the activation 
of vitamin K-dependent proteins. In the first step, they are reduced to their semiquinone form by a 
quinone reductase (NADH dehydrogenase). This reduced form acts as a co-factor to the gamma-
carboxylase  which  carboxylates  glutamyl  residues  to  gamma-carboxy-glutamic  acid  residues  on 
certain proteins (Gla proteins). Gla proteins are important for normal blood coagulation, known for 
more than 60 years, and normality of bones and arteries (for details see Vermeer and Schurgers, 2000). 
Each converted glutamyl residue produces a molecule of vitamin K epoxide which is returned to 
vitamin K via the vitamin K epoxide reductase. 
Vitamin K is included in the European Union Register of Feed Additives pursuant to Regulation (EC) 
No 1831/2003 and foreseen for re-evaluation. It is authorised as a nutritional additive for use in all 
animal species without time limit and maximum content. 
The applicant asks for the re-evaluation of the use of vitamin K3 (nutritional additive, functional group 
vitamins, pro-vitamins and chemically well-defined substances having similar effects) in the form of 
menadione sodium bisulphite (MSB) and menadione nicotinamide bisulphite (MNB) for use in feed 
for all animal species and categories and for a new use of vitamin K3 in the form of MSB in water for 
drinking. 
Menadione is described in the European Pharmacopeia (PhEur, 2010) as Monograph (MG) 0507. 
Menadione  (and  phytomenadione)  is  listed  as  a  pharmacologically  active  substance  in  veterinary 
medicinal products
9 and not subject to maximum residue levels when used in food-producing animals. 
                                                       
9  Commission  Regulation  (EU)  37/2010  of  22  December  2009  on  pharmacologically  active  substances  and  their 
classification regarding maximum residue limits in foodstuffs of animal origin. OJ L 15, 20.1.2010, p. 1. Vitamin K3 for all animal species 
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Menadione (and phytomenadione) is listed as an ingredient in cosmetic products as a masking agent 
and skin conditioning agent.
10  
Vitamin K in the form of phylloquinone (phytomenadione) and menaquinone is authorised for use in 
food
11 and food supplements,
12 and for addition to foods for particular nutritional uses.
13 Vitamin K in 
the form of phylloquinone (phytomenadione) is authorised   for addition to processed cereal -based 
foods and baby foods for infants and young children
14 and to infant formulae and follow-on formulae 
when reconstituted as instructed by the manufacturer.
15  
2.  Characterisation 
2.1.  Menadione sodium bisulphite  
2.1.1.  Characterisation 
Menadione  sodium  bisulphite  (IUPAC  name:  1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-2-
naphthalenesulfonic  acid,  sodium  salt  trihydrate;  synonyms:  vitamin  K3,  MSB)  is  identified  by 
Chemical  Abstracts  Service  (CAS)  number  6147-37-1  and  the  European  Inventory  of  Existing 
Chemical  Substances  (EINECS)  number  204-987-0  (anhydrous).  The  structural  formula  of  MSB 
trihydrate is shown in Figure 1. 
       
Figure 1:   Structural formula of menadione sodium bisulphite trihydrate 
The molecular formula of MSB is C11H9NaO5S
.3H2O and its molecular weight is 330.29. It has a 
melting point of 121–124 °C, a bulk density of approximately 700–800 kg/m
3 and is freely soluble in 
water (0.5 g/mL), slightly soluble in alcohol and almost insoluble in benzene and diethyl ether. 
MSB is a free-flowing white to yellowish crystalline, practically odourless, powder. The additive 
contains by specification ≥ 50 % menadione, ≤ 13 % water (as hydrate), ≤ 5 % free sodium bisulphite 
and ≤ 100 mg Cr/kg. The minimum content of 50 % menadione would correspond to 96 % MSB 
trihydrate  complex.  Analysis  of  five  batches  (from  two  different  producers)  showed  an  average 
content of 51.0 % menadione (range: 50.3–51.5 %).
16 Free sodium bisulphite was between 3.1 and 
4.4 % and water between 10.8 and 12.0 %.  
                                                       
10   Commission Decision 2006/257/EC of 9 February 2009 amending Decision 96/335/EC establishing an inventory and a 
common nomenclature of ingredients employed in cosmetic products. OJ L 97 5.04.2006, p. 1. 
11   Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404 30.12.2006, p. 26. Last amended by Commission 
Regulation (EC) No 1170/2009 of 30 November 2009 amending Directive 2002/46/EC of the European Parliament and of 
Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards the lists of vitamin 
and minerals and their forms that can be added to foods, including food supplements. OJ L 314 1.12.2009, p. 36. 
12   Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183 12.7.2002, p. 51. 
13 Commission Regulation (EC) 953/2009 of 13 October 2009 on substances that may added for specific nutritional purposes 
in foods for particular nutritional uses. OJ L 269, 14.10.2009, p. 9. 
14 Commission Directive 2006/125 EC of 5 December 2006 on processed cereal-based foods and baby-foods for infants and 
young children. OJ L 339 6.12.2006, p. 16. 
15 Commission Directive 2006/141 EC of 22 December 2006 on infant formulae and  follow-on formulae and  amending 
Directive 1999/21/EC. OJ L 401 30.12.2006, p. 1. 
16 Technical dossier/Section II. Vitamin K3 for all animal species 
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Chromium  was  in  the  range  30–45 mg/kg  and  heavy  metals  (expressed  as  lead)  were  below 
20 mg/kg.
16 The concentrations of cadmium, mercury, lead and arsenic determined in three additional 
batches were ≤ 0.3 mg/kg, < 0.01 mg/kg, ≤ 0.2 mg/kg and ≤ 0.1 mg/kg, respectively.
17 The content of 
residual solvents (ethanol determined in two batches 176–208 mg/kg or n-butanol determined in three 
batches  17.5–37.4 mg/kg)  was  below  the  thresholds  proposed  by  International  Cooperation  on 
Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH) 
(EMA, 2010). 
Two batches of MSB (one from each producer) were analysed for particle size distribution by laser 
diffraction. The particle fraction below 50 µm was 14.3 % and 19.6 % (v/v).
18 Another two batches of 
the substance showed a dusting potential of 15.4 g/m
3 (average of three repeated measurements)
19 and 
3.1 g/m
3 (average of five repeated measurements).
20 The content of chromium in the dust determined 
in the latter batch was 182 mg/kg.
21 The respirable fraction (< 10 µm) of the dust amounted to 54 %.
22 
Menadione is obtained by oxidation of  2-methylnaphthalene using sodium dichromate (Na2Cr2O7) as 
catalyst. MSB is then produced by reaction of menadione with sodium bisulphite in ethanol or n-
butanol. After decolorisation on active carbon or diatomaceous earth, the crude product is crystallised, 
centrifuged, washed with ethanol or n-butanol, and dried. The applicant provided a flow chart of the 
synthetic process. 
2.1.2.  Stability and homogeneity 
MSB is stable when exposed to air but is sensitive to light and heat. In alkaline media (pH > 11), MSB 
is converted to menadione (Demirkaya-Miloglu et al., 2013).  
MSB (three batches, stored in sealed plastic bags) was demonstrated to have a shelf life of 18 months, 
when stored at 25 ± 5 °C. No data from tests under accelerated conditions  were submitted, but at 
higher temperature the risk of discoloration, indicating loss of activity, increased after 12 months.
23 
The stability of MSB was tested when incorporated in three different premixtures —(i) without trace 
elements (at 2 000 mg MSB/kg), (ii) with trace elements (at 400 mg MSB/kg) and (iii) with trace 
elements and choline (at 400 mg MSB/kg)—and stored in sealed plastic bags at 30 °C. Recovery of 
MSB was 84.2 %, 82.3 % and 72.7 %, respectively, after one month, and 71.1 %, 67.2 % and 49.6 % 
after three months.
24 The data indicate that stability of MSB will be strongly affected by choline and to 
a lesser extent by trace elements. This is in accordance with the literature. Stability data published by 
BASF (1994, cited by Whitehead, 2002) showed a recovery of MSB in premixtures containing choline 
chloride and trace minerals of 64 % after one month and of 0 % after six months‘ storage. 
A new stability study to demonstrate stability for six months was performed upon request. MSB was 
incorporated at the level of about 30 mg/kg in a mineral/amino acid premixture without trace elements 
and  choline.  Owing  to  inconsistent results  (decline  of  MSB  until  three  months  and  a  subsequent 
increase after six months‘ storage) the data were not considered further.
24 
The stability of MSB (one batch) was tested during processing  of maize–soya bean meal-based feed 
(pelleting at 90  C) and storage (30 °C, 70–80 % humidity, sealed plastic bags). Pelleting reduced 
MSB to about 53 % of the initial content (6 mg MSB/kg feed). Storage of the pelleted samples for two 
months (30 ± 5 °C) reduced the MSB content further, to about one-third of the initial level.
24  
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Data published by BASF (1994, cited by Whitehead, 2002) suggest an inverse correlation between 
MSB stability in compound feed and the temperature used during expansion. At 93  C for 30 seconds 
(or 110  C for 5 seconds) recovery was 80 %, and at 149  C for 30 seconds (or 165  C for 5 seconds) 
recovery was 30 %. 
In  commercial  fish  feed  (Marchetti  et  al.,  1999)  supplemented  with  60 mg  MSB/kg,  the  initial 
concentration was reduced by 50 % after pelleting and by 66 % after extrusion. Storage of pelleted and 
extruded feed, for three months resulted in a further loss of 31 % and 38 %, respectively. 
The stability of MSB (one batch) in water for drinking at a concentration of 2.5 g/L was shown when 
stored for up to 24 hours at 20 °C.
24 In a second submission, a solution containing 1.1 g MSB/L water 
was shown to be stable for up to 48 hours, at both 15 °C and 25 °C.
25 Although the data apparently 
demonstrate stability, it is questionable if they can be extrapolated to practical concentrations of MSB 
in water for drinking, which are about 100 to 1 000 times lower. 
To assess the capacity of the additive to homogeneously distribute in feed, the applicant performed a 
statistical calculation (Jansen, 1992). The coefficient of variation of the MSB concentration in poultry 
feed was calculated to be approximately 8 %. However, this method has been developed to test the 
working accuracy of mixing equipment and is not accepted by the FEEDAP Panel as a valid method 
for assessing the capacity of the additive to distribute homogeneously in feedingstuffs. 
As  MSB  is  highly  soluble  in  water,  homogeneity  in  water  for  drinking  does  not  need  to  be 
demonstrated. 
2.2.  Menadione nicotinamide bisulphite  
2.2.1.  Characterisation 
Menadione  nicotinamide  bisulphite  (IUPAC  name:  1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-2-
naphthalenesulfonic  acid  compound  with  3-pyridinecarboxamide;  synonyms:  2-
methoxysulfonyltetralin-1,4-dione with pyridine 3-carboxamide, MNB, vitamin K3) is identified by 
the CAS number 73581-79-0 and the EINECS number 277-543-7. The structural formula of MNB is 
shown in Figure 2. 
 
Figure 2:   Structural formula of menadione nicotinamide bisulphite  
The molecular formula of MNB is C11H9O5S
.C6H7N2O and its molecular weight is 376.42. It has a 
boiling point of 193–198 °C, shows a bulk density of 700–800 kg/m
3 and is sparingly soluble in water 
(19 g/L at 20 C). 
MNB is a free-flowing yellowish odourless powder. The additive contains by specification ≥ 44 % 
menadione, ≥ 31 % nicotinamide, ≤ 1 % water and ≤ 150 mg Cr/kg. The minimum content of 44 % 
menadione would correspond to 96 % MNB complex. Analysis of five batches (from two different 
producers) showed an average content of 44.1 % menadione (range 43.9–44.2 %).
26 Nicotinamide was 
between 31.2 and 32.4 % and water between 0.2 and 0.5 %.  
                                                       
25 Technical dossier/Supplementary information October 2012/Annex Qii. 
26 Technical dossier/Section II. Vitamin K3 for all animal species 
 
EFSA Journal 2014;12(1):3532  12 
Chromium  was  in  the  range  77–142 mg/kg  and  heavy  metals  (expressed  as  lead)  were  below 
20 mg/kg.
26 The concentrations of cadmium, mercury, lead and arsenic determined in three additional 
batches  were  < 0.01 mg/kg,  < 0.01 mg/kg,  ≤ 0.2 mg/kg  and  < 0.1 mg/kg  respectively.  The 
concentration  of  chromium  in  the  same  batches  ranged  from  90  to  117 mg/kg.
27  The content of 
residual solvents (ethanol determined in three batches 4.1–13.3 mg/kg or n-butanol determined in two 
batches 19.5–44.7 mg/kg) was below the thresholds proposed by VICH (EMA, 2010).  
Two batches of MNB (one from each producer) were analysed for particle size distribution by laser 
diffraction. The particle fraction below 50 µm was 7.9 % and 1.6 %.
28 Another two batches of the  
additive  showed a dusting potential of 0.39  g/m
3  (average  of  three  repeated  measurements)
29  and 
0.46 g/m
3 (average of four repeated measurements).
30 The content of chromium in the dust determined 
in the latter batch was 71 mg/kg.
31 The respirable fraction (below 10 µm) in the dust was 34 %.
32 
Menadione is obtained by oxidation of  2-methylnaphthalene using sodium dichromate (Na2Cr2O7) as 
catalyst. MNB is prepared by reaction of menadione with nicotinamide in aqueous sulphuric acid. The 
crude product is then centrifuged, washed with ethanol or n-butanol, and dried. The applicant provided 
a flow chart of the synthetic process. 
2.2.2.  Stability and homogeneity 
MNB is stable when exposed to air, but is sensitive to light and heat.  
MNB (three batches, stored in sealed plastic bags) showed a shelf life of 30 months when stored at 
25 ± 5 °C. No data from tests under accelerated conditions were submitted, but at higher temperature 
the risk of discoloration, indicating loss of activity, increases after 24 months.
33 
The stability of MNB was tested when incorporated in three different premixtures —(i) without trace 
elements (at 2 273 mg MNB/kg), (ii) with trace elements (at 455 mg MNB/kg) and (iii) with trace 
elements and choline (at 455 mg MNB/kg)—and stored in sealed plastic bags at 30 °C. Recovery of 
MNB was 93.1 %, 91.3 % and 87.2 %, respectively, after one month and 82.3 %, 80.9 % and 73.5 % 
after three months.
34 The data indicate that stability of MNB will be affected by choline. 
A new stability study to demonstrate stability for six months was performed upon request. MNB was 
incorporated at the level of about 20 mg/kg in a mineral/amino acid premixture without trace elements 
and choline. Owing to inconsistent results (e.g. increase of MNB after nine weeks by 73 %) the data 
were not considered further.
34 
The stability of MNB (two batches) was tested during  pig feed processing (pelleting at 70  C) and 
storage (30 ± 5 °C). Pelleting reduced MNB by about 52  % of the initial content (4.5  mg MNB/kg 
feed). Storage of pelleted  feed for three months did not further reduce MNB content in one batch , 
whereas in another batch MNB content was reduced to about one-third of the initial level.
34 
However,  Graff  et  al.  (2010)  added  increasing  amounts  of  MNB  to  salmon  diets  (10,  100  and 
1 000 mg  menadione/kg  feed),  which  was  produced  according  to  commercial  manufacturing 
procedures, and found recovery of only 3–5 % two months after production. 
To assess the capacity of the additive to homogeneously distribute in feed, the applicant performed a 
statistical calculation (Jansen, 1992). The coefficient of variation of the MSB concentration in poultry 
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feed was calculated to be approximately 11 %. However, this method has been developed to test the 
working accuracy of mixing equipment and is not accepted by the FEEDAP Panel as a valid method 
for assessing the capacity of the additive to distribute homogeneously in feedingstuffs. 
2.3.  Physico-chemical incompatibilities in feed 
No physico-chemical incompatibilities or interactions have been reported between MSB or MNB and 
feed materials, carriers or feed additives (except choline chloride) when the additive was added to 
premixtures and feed. No such incompatibilities or interactions are expected. 
2.4.  Conditions of use 
Vitamin K3 in the form of MSB and MNB is intended for use in all animal species and categories 
without  maximum  limit.  MSB  and  MNB  are  intended  for  use  in  feed  (premixtures,  complete  or 
complementary feed) and it is recommended that they be incorporated in compound feed only via 
premixtures. MSB is intended also for use in water for drinking. 
2.5.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
EFSA has verified the EURL report as it relates to the methods used for the control of vitamin K3 
(menadione)  in  animal  feed.  The  Executive  Summary  of  the  EURL  report  can  be  found  in  the 
Appendix. 
3.  Safety 
According to Regulation (EC) No 429/2008, tolerance, metabolism and residue, and toxicological 
(concerning  consumer  safety)  studies  are  not  required  for  vitamins,  pro-vitamins  and  chemically 
defined  substances  having  similar  effects  which  are  already  authorised  as  feed  additives  under 
Directive 70/524/EEC and which do not have the potential to accumulate, which the FEEDAP Panel 
considers is the case for vitamin K3 in the form of MSB and MNB. 
The FEEDAP Panel notes that MNB is also a source of nicotinamide. The safety of nicotinamide as 
feed additive for all animal species has been recently assessed by the FEEDAP Panel (EFSA FEEDAP 
Panel, 2012). 
3.1.  Absorption, distribution, metabolism and excretion 
A detailed description of the absorption and metabolism of vitamin K can be found  in the IARC 
monograph (2000) and Scientific Committee on Food (SCF) assessment (EC, 2003). 
Phylloquinone administered orally to mammals and birds is absorbed and partly converted into MK-4 
via integral side-chain removal and replacement, which implies that menadione is an intermediary 
metabolite (Martius, 1967; Hirota et al., 2013; Dialameh et al., 1970). Menadione release occurs in the 
intestine, its prenylation into MK-4 occurring in the intestine and tissues (Okano et al., 2008). Caco-2 
cells exposed to menadione produced MK-4 (Al Rajabi et al., 2012). Part of the MK-4 in tissues 
results  from  uptake  and  alkylation  (prenylation)  of  circulating  menadione  (Thijssen  et  al.,  1996). 
Menadione  urinary  excretion  in  humans  increases  greatly  after  oral  intake  of  phylloquinone 
(amounting to 5 to 25 % of the administered dose) but also after intake of MK-4 or MK-7 (Thijssen et 
al., 2006). In isolated rat hepatocytes, cellular glutathione (GSH) reacted directly with menadione to 
produce a GSH–menadione conjugate (Di Monte et al., 1984). The same conjugate was identified in 
the  Hep  G2  cell  line  (Mouzaroll  et  al.,  2004).  The  side  chains  of  phylloquinone  and  MK-4  are 
shortened  by  the  rat  to  seven  carbon  atoms  (ω-oxidation  followed  by  β-oxidation),  yielding  a 
carboxylic acid group at the end that cyclises to form a γ-lactone which is excreted in the urine, 
presumably as a glucuronic acid conjugate. Recently, glutathione– and N-acetylcysteine–menadione 
conjugates  were  identified  in  the  rat  plasma  after  intraperitoneal  administration  of  menadione 
(Elgawish et al., 2013). Vitamin K3 for all animal species 
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Vitamins K1, K2 and K3 are metabolically activated in the liver to become co-factors in the activation 
of vitamin K-dependent proteins. In the first step, they are reduced to their semiquinone form by a 
quinone reductase (NADH dehydrogenase). This reduced form acts as a co-factor to the membrane 
enzyme vitamin K-dependent gamma-carboxylase, which carboxylates glutamyl residues to gamma-
carboxy-glutamic acid residues on certain proteins, activating them. Each converted glutamyl residue 
produces a molecule of vitamin K epoxide, which is returned to vitamin K via the vitamin K epoxide 
reductase enzyme, also an integral membrane protein. 
Phylloquinone is the major type (> 90 %) of dietary vitamin K. Its concentration in animal tissues is 
remarkably low compared with menaquinones, the major forms (> 90 %) of vitamin K in tissues. MK-
7 to MK-10 have been found as the major compounds in pig liver, and MK-10 to MK-12 have been 
found in beef. MK-4 and saturated MK-4 (H4) were found also in the liver of these species and rabbit 
and  chicken  (review  from  Duello  and  Matschiner,  1972).  Generally,  as  shown  in  the  rat,  MK-4 
concentrations are low in liver and plasma, the greatest accumulations being observed in non-hepatic 
organs  (pancreas,  salivary  gland  and  brain)  (Thijssen  et  al.,  1996).  The  conversion  of  dietary 
menadione into MK-4 has been shown to occur in the liver of fish (Grahl-Madsen and Lie, 1997; 
Ostermeyer and Schmidt, 2001; Graff et al., 2002) and chicks (Will et al., 1992).  
No direct evidence of release of menadione from its complexes sodium bisulphate and nicotinamide is 
available. The bioavailability of menadione and nicotinamide, measured as plasma concentration of 
both vitamins, was shown to be similar in pigs administered either MNB or an equivalent quantity of 
menadione and nicotinamide given separately (Marchetti et al., 2000). In pre-ruminant calves, MSB 
was converted to MK-4, which was found at high concentration in the faeces, implying the release of 
menadione and isoprenylation by the intestinal flora; only MK-4 was found as a metabolite in intestine 
tissue, liver and spleen (Nestor and Conrad, 1990). 
Thus, it is expected that residues of vitamin K3 in animal products, if any, will be low and common to 
metabolites of phylloquinone, the predominant vitamin K in feedingstuffs. 
3.2.  Toxicological profile  
Toxic effects of the vitamin K family are manifested mainly as haematological disorders. However, 
marked differences are observed among the toxicity potentials of the various vitamin K compounds. 
3.2.1.  Vitamin K3 
The applicant, citing studies but without providing the full report, provided data on acute oral toxicity 
in rats in a limit test on MSB and MNB which showed no mortality at doses of 2 000 and 5 000 mg/kg 
body weight (bw), respectively.
35 
In a single-dose oral toxicity study in chicks (eight days of age), 3 630 mg MNB/kg bw caused 25 % 
mortality and growth depression in a 14 -day post-treatment observation period. In a 14 -day feeding 
study in chicks (days 8 to 22), 681 mg MNB/kg diet did not affect growth rate, feed intake, feed to 
gain ratio or blood haemoglobin when compared with an unsupplemented control diet (Oduho et al., 
1993).  
Acute oral doses of menadione were slightly toxic in chicks and mice, with  a median lethal dose 
(LD50) of about 800 and 600 mg/kg bw, respectively (Molitor and Robinson, 1940; Ansbacher et al., 
1942). The main toxicity symptoms were haemolysis and anaemia associated with Heinz bodies in the 
erythrocytes  and  spleen  enlargement  (Munday  et  al.,  1991).  In  rats  given  oral  gavage  doses  of 
menadione for 30 days, 500 mg/kg bw per day was lethal and 350 mg/kg bw per day caused marked 
reductions in erythrocyte count and haemoglobin (Molitor and Robinson, 1940).  
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3.2.2.  Vitamin K1 and K2 
The natural forms of vitamin K, phylloquinone and menaquinone, are non-toxic at very high dosage 
levels. Acute oral doses of phylloquinone up to 25 000 mg/kg bw caused no fatalities in mice (Molitor 
and Robinson, 1940).  
Vitamin K2, MK-7, was tested for acute oral toxicity in mice using a limit test in accordance with 
OECD Guideline 425. Five female mice (Bontac: NMRI strain) were given a single oral dose of 
2 000 mg  MK-7/kg  bw  in  corn  oil  and  observed  for  14  days.  Two  untreated  mice  were  kept  as 
controls. Mortality and body weight gain were unaffected by the treatment (Pucaj et al., 2011). 
The repeated-dose oral toxicity of MK-7 was tested in a 90-day study in groups of 15  Sprague–
Dawley rats of each sex given daily gavage doses of 0, 2.5, 5.0 or 10.0 mg MK-7/kg bw in corn oil. 
Ten rats of each sex were killed on day 90 and the remainder were retained for an untreated recovery 
period of 30 days. Blood samples were collected on day 44 from five males and five females from 
each group, and a limited range of haematological and clinical parameters were examined. Urine was 
collected for analysis during the final week of treatment and the final week of recovery. No adverse 
effects were seen on mortality, body weight gain, clinical appearance, ophthalmology or in a battery of 
functional observation tests. The only statistically significant haematological effect was an increase in 
activated partial thromboplastin time (without affecting prothrombin time) in the mid- and top-dose 
females. The effect was due to unusually high partial thromboplastin time in three of the rats and was 
probably  not  treatment  related.  There  were  no  effects  on  clinical  biochemistry  or  urinalysis 
parameters.  There  were  also  no  treatment-related  effects  on  organ  weight,  gross  pathology  or 
histopathology. In summary, no treatment-related effects of MK-7 were seen in this study (Pucaj et al., 
2011). 
Repeat-dose oral toxicity studies were conducted with rats and dogs receiving MK-4 doses for a 
period of one year (Hosokawa et al., 1995; Vanatta et al., 1995).  
Hosokawa  et  al.  (1995)  administered  menatetrenone  (synthetic  MK-4)  to  Fisher  344  rats 
(20/sex/group) at dietary concentrations of 0.04, 0.2 or 1.0 % (approximately 20, 100 and 500 mg/kg 
bw per day, respectively). Two control groups were used: one was called ‗control‘ and the other 
‗naïve‘. There were no treatment-related effects on food intake, body weight, mortality, clinical signs 
of toxicity. Haematology of females showed dose-related and significant (t-test; P < 0.05) reductions, 
compared with ‗controls‘, in erythrocyte counts in all treated groups, and in packed cell volume and 
haemoglobin  in  the  mid-  and  high-dose  groups,  while  significant  elevations  were  seen  in  mean 
corpuscular volume and platelet count in all treated groups and in the lymphocyte to neutrophil ratio in 
the  high-dose  group  of  females.  In  males,  there  were  significant  decreases  in  haemoglobin  and 
prothrombin time in all dose groups, although not dose-related, in activated partial thrombin time in 
the mid- and high-dose groups and in erythrocyte count and mean corpuscular volume only in the 
high-dose  group,  along  with  an  elevated  platelet  count  in  the  high-dose  group.  The  changes  in 
haematological parameters were either less marked or did not occur when the results for treated groups 
were compared with the ‗naïve‘ rather than the ‗control‘ group.  
Whilst there were some statistically significant changes in some blood biochemistry parameters, none 
was considered to be treatment related as there was inconsistency between sexes, a lack of dose–
response  relationships  and/or  an  absence  of  associated  lesions  seen  on  gross  pathology  and 
histopathology. Urine analyses were unremarkable. Dose-dependent increases in absolute and relative 
spleen weights in the mid- and high-dose groups of both sexes were accompanied by histopathological 
changes  that  indicated  increased  extramedullary  haematopoiesis  and  increased  haemosiderin 
deposition.  Other  significant  organ  weight  differences,  which  were  not  associated  with  any 
histopathology, included a small but dose-dependent increase in relative kidney weights in both sexes 
(statistically significant in the mid- and high-dose groups). Increased relative liver and adrenal and 
sub-maxillary gland weights were noted in all female dose groups, and elevated absolute liver weight, 
and relative brain and thyroid gland weights in the mid- and high-dose female groups. The FEEDAP Vitamin K3 for all animal species 
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Panel regarded the no observed adverse effect level (NOAEL) for this study to be 0.04 % (equivalent 
to 20 mg/kg bw per day) based on haematological changes and changes in the spleen, which were seen 
in both sexes at 0.2 % or greater.  
Menatetrenone (synthetic MK-4) was provided orally in capsules to groups of six male and six female 
dogs at doses of 0, 20, 200 or 2 000 mg/kg bw per day for a period of one year followed by a three-
month observation period (Vanatta et al., 1995). Blood was collected after 3, 6 and 12 months of 
treatment and at the end of the recovery period. Some of the dogs (unspecified number) were killed for 
autopsy at the end of the 12-month treatment period and the remainder were killed at the end of the 
recovery period. There were no treatment-related effects on mortality, body weight gain or food and 
water consumption, and no ophthalmoscopic changes. Yellow faeces and yellow coat stains were 
observed in animals in the high-dose (2 000 mg/kg bw per day) group, but no other clinical signs were 
reported. In high-dose female dogs, significant increases (P < 0.05) in reticulocyte count were seen at 
6 and 12 months, whereas in males the platelet count was elevated in the high-dose group at 12 
months. In females there was increased serum alkaline phosphatase activity in the high-dose group 
that was significant at 6 and 12 months. Significantly reduced serum sodium levels were noted in all 
treated males at 12 months, while decreases in serum triglycerides were seen in high-dose males at 6 
and 12 months and serum alanine aminotransferase was elevated in males in the high-dose group at 6 
months. The haematological and clinical chemistry changes observed appeared to be reversible once 
MK-4 treatment was ceased. No effects on absolute organ weight were noted in either sex, but a dose-
dependent increase in relative liver weights was observed in high-dose males that were killed at the 
end of the treatment period. At necropsy conducted immediately following the treatment period, gross 
examination revealed yellow body fat in two high-dose males. A NOAEL of 200 mg/kg bw per day 
was  established  for  MK-4  administered  orally  to dogs,  based  on  yellow  coloration  of  faeces  and 
various changes in blood parameters which were seen at 2 000 mg/kg bw per day.  
3.3.  Safety for the target species 
The vitamin K requirement of target animals is met by a combination of dietary intake and microbial 
biosynthesis  in  the  gut  (which  could  become  orally  available  by  coprophagia),  which  involves 
intestinal  microorganisms  (such  as  Escherichia  coli)  as  well  as  ruminal  microbes.  Ruminal 
microorganisms in particular synthesise large amounts of vitamin K, explaining why ruminants do not 
appear to need a dietary source of the vitamin. Because of microbial synthesis and high content of 
forages, a precise expression of vitamin K requirements for ruminants, horses and lagomorphs is not 
feasible (NRC, 1996, 2001, 2007a, b; GfE, 1995, 2001, 2003, 2014 in press).  
Requirements for menadione are in the range 0.5–1.8 mg/kg feed for poultry (NRC, 1994), 0.5 mg/kg 
for pigs (NRC, 2012), 0.2–10 mg/kg for fish (NRC, 2011) and 1.0–1.3 mg/kg for pets (NRC, 2006). 
The German Society of Nutrition Physiology (Gesellschaft für Ernährungsphysiologie, GfE) proposed 
the following ranges for vitamin K requirements (as vitamin K3): 0.6–1.5 mg/kg feed for poultry (GfE, 
1999, 2004) and 0.1–0.15 mg/kg for pigs (GfE, 2008). 
It should be noted that the requirement data may have a high degree of uncertainty since they refer to 
intended supplementation values. Modern feed-producing techniques (e.g. extrusion) may result in 
considerable losses. The real requirements may therefore be considerably lower. They require at least 
a new assessment (Graff et al., 2010). 
Vitamin  K3  supplementation  of  commercial  compound  feed  is  mainly  oriented  towards  meeting 
recommended allowances (probably also considering the reduced stability), which are in the range of 
2–4 mg menadione/kg feed for pigs, 1–4 mg/kg for poultry, 4–8 mg/kg for fish and 1 mg/kg for pets 
(AWT, 2002). A survey of vitamin supplementation of commercial feeds for pigs and poultry in 
Europe (Belgium, Denmark, Germany, Italy, Netherlands, Portugal, Spain and the United Kingdom) 
identified a range of 0–6.3 mg vitamin K3/kg as commercial use levels (Gropp, 1994). A range for 
piglets and pigs of 1–5 mg menadione/kg feed was reported by Whittemore et al. (2002). Vitamin K3 for all animal species 
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No data on the tolerance of animal species including fish were provided by the applicant. Only three 
studies, one in lovebirds, one in laying hens and another one in Atlantic salmon, which could be 
considered as indicative of tolerance to vitamin K were found. 
The tolerance of lovebirds (Agapornis spp.) to MSB has been studied using three groups of birds fed 
pelleted diets containing 0, 20 or 200 mg MSB/kg (analytically confirmed) for 10 months (Wolf et al., 
2005). No adverse effects of vitamin K3 were seen on feed and water intake, quality of excreta, 
growth, reproduction status, haemotogram, clinical blood biochemistry, pathology (four birds each 
after  6 and  10  months). The  authors  concluded from  liver  vitamin  K  levels that  MSB is  rapidly 
metabolised. The data show that MSB up to 200 mg/kg diet is tolerated by lovebirds. Consequently, 
20 mg MSB/kg is considered safe for all other ornamental birds. 
Suzuki and Okomoto (1997) fed laying hens with 1 000 mg MSB/kg diet for 31 days. No adverse 
effects on feed intake and laying performance were found. 
Graff  et  al.  (2010)  supplemented  salmon  diets  with  MNB  to  provide  0,  10,  100  or  1 000 mg 
menadione/kg. The recovery in feed was only 3–5 % of the intended values. Since requirement data 
are in the range 1–10 mg menadione/kg, the study provides a rather low margin of safety for MNB for 
fish. 
3.3.1.  Interactions 
3.3.1.1.  Interactions with fat-soluble vitamins 
Interactions  between  the  fat-soluble  vitamins  retinol,  cholecalciferol,  tocopherol  and 
phylloquinone/menaquinone have been widely described in the literature (e.g. Matschiner et al., 1967; 
March et al., 1973; Abawi and Sullivan, 1989; Grisdale-Helland et al., 1991; Traber, 2008; Farley et 
al., 2012). In short, overdoses of one fat-soluble vitamin seem to require comparable overdosing of 
other  fat-soluble  vitamins  to  compensate  for  adverse  effects.  These  interactions  are  of  scientific 
interest but of little or no relevance for common feeding practice, since they are expected to occur only 
at concentrations above the legal thresholds for retinol and cholecalciferol.  
3.3.1.2.  Interactions with antagonists 
Dicoumarol and coumarin derivates (e.g. warfarin) are well known anticoagulants acting as vitamin K 
antagonists, increasing the vitamin K requirement of the animals. Actinomycin D antagonises the 
prothrombin formation induced by vitamin K3 in chicks (Olson, 1964). Scott et al. (1982) concluded 
that coccidiosis causes an increased requirement for vitamin K. 
Some broad-spectrum antibiotics may interact with microbial synthesis of vitamin K2 in the intestine 
(Conly and Stein, 1994; Shearer, 1995; Hendler and Rorvik, 2001), reducing the supply to the animal. 
Similar effects have been described with sulphonamides in the diet. Nelson and Norris (1961) showed 
that the inclusion of 0.1 % sulphoquinoxaline increased the chick‘s need for supplemental vitamin K 
by four- to seven-fold.  
3.3.2.  Chromium 
Since sodium dichromate (Na2Cr2O7) is used as catalyst in the manufacture of the additive (see section 
2.1.1), it is assumed that chromium in MSB (30–45 mg/kg) and MNB (77–142 mg/kg) is hexavalent 
chromium (Cr(VI)); speciation was not provided despite being requested. Cr(VI) is an established 
human and animal carcinogen, including when ingested (Witt et al., 2013). Evidence indicates also a 
potential  for  endocrine  disruption  (EFSA,  2009b).  A  conservative  estimate  of  the  contribution  of 
vitamin K3 sources to the chromium content of complete feed is made assuming that (i) MNB is used, 
(ii)  the  dose  in  complete  feed  is  10 mg  menadione/kg,  equivalent  to  20 mg  MNB/kg,  (iii)  the 
chromium content of MNB is 150 mg/kg (by specification) and (iv) chromium in MNB is Cr(VI). 
Based on these assumptions, 3 µg chromium would be added to 1 kg complete feed. Background 
concentrations of chromium in feed would be between 0.2 and 7 mg/kg and it is expected that about Vitamin K3 for all animal species 
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10 % would exist as Cr(VI) (EFSA, 2009b; Soares et al., 2010; Mandiwana et al., 2011). Thus, a 
highly conservative estimate is that the sources of vitamin K3 under assessment would add 0.4 to 15 % 
of the background of Cr(VI) to feed. It should be noted that soluble Cr(VI) compounds are unstable 
and readily reduced to Cr(III) in the presence of electron donors such as organic matter or reducing 
inorganic compounds. It is therefore likely that the contribution of the additive to the total chromium 
content in feed would mostly be as Cr(III), which has low oral toxicity (NOAEL (rat) = 286 mg/kg bw 
per day; NTP, 2010). Although a full assessment of the risk arising from the intake of chromium from 
vitamin K3 sources for the target animals is not possible, owing to the lack of data on chromium 
speciation, the FEEDAP Panel considers the risk from added chromium as negligible. 
Making the same assumptions as those above for the addition of the MSB in feed, water for drinking 
would  contain  3 µg/L  of  added  chromium  when  MSB  is  added  to  water  for  drinking.  Natural 
concentrations in surface waters range from 0.3 to 6 µg/L (Rakhunde et al., 2012). The carcinogenic 
Cr(VI) is a major chromium species in water, and the addition of MSB to water for drinking would 
likely increase the exposure of target animals to Cr(VI). The added risk may be marginal but cannot be 
ignored. 
3.3.3.  Conclusions on the safety of MSB and MNB for target species  
Acute toxicity to menadione or its derivatives is reached at levels exceeding the requirements by a 
factor of at least 1 000. Few and incomplete data on lovebirds, laying hens and salmon indicate that 
tolerated vitamin K concentrations in feed exceed the requirements by factors of 5 to 1 000. It is 
concluded  that  MSB  and  MNB  are  safe  for  all  animal  species  at  practical  use  levels.  Setting  a 
maximum content for MSB and MNB in feed is not considered necessary. 
The addition of chromium as a contaminant in MSB and MNB is not a concern for its use in feed, but 
would likely add to Cr(VI) exposure if used in water for drinking. The FEEDAP Panel has therefore 
some concerns regarding the safety of the latter application. 
3.4.  Safety for the consumer 
3.4.1.  Tolerable upper intake level (UL) 
There are insufficient data to establish a safe upper level for vitamin K in humans. The SCF identified 
an adequate intake of 1 µg vitamin K/kg bw per day in adults, which would be provided by a normal 
diet (EC, 2003). According to the UK Expert Group on Vitamins and Minerals, a daily supplementary 
intake of 1 mg/day (equivalent to 17 µg/kg bw in a 60-kg adult) would be unlikely to result in adverse 
effects (EVM, 2003). 
3.4.2.  Consumer exposure  
According to the SCF (EC, 2003), the mean intake of phylloquinone in the USA ranges between 60 
and  110 µg  phylloquinone/day  in  young  adults  (< 45  years),  and  between  80  and  210 µg 
phylloquinone/day in older adults (> 45 years) because of their greater vegetable consumption. In a 
longitudinal study performed in the UK in 1985, the mean estimate for men and women aged 40–59 
years was 67 and 69 µg phylloquinone/day, respectively. At follow-up 10 years later the intakes had 
fallen to 54 and 56 µg phylloquinone/day, respectively, for men and women then aged 50–60 years. 
For people aged 65 years and over, mean intakes for men and women were 66 and 57 µg/person/day, 
respectively. The EVM reported a mean intake of 68 µg/day, and an estimated maximum intake of 
270 µg/day including supplements (EVM, 2003). In The Netherlands, mean daily per capita intake 
was estimated to be up to 250 µg as a consequence of the relatively high intake of green vegetables. 
For menaquinone intake there are no population-based data available except for The Netherlands, 
where menaquinones are estimated to account for about 10 % of total vitamin K intake (Schurgers et 
al., 1999). Based on the average per capita food consumption in Finland (Ministry of Agriculture and 
Forestry,  2000;  Statistics  Finland,  2000,  cited  by  EC,  2003),  the  average  vitamin  K  intake  from 
different foods was estimated to be 120 µg/day (Koivu-Tikkanen, 2001). The more recent German 
food surveys (Nationale Verzehrsstudie, 2008 and 2013) do not include data on the vitamin K intake. Vitamin K3 for all animal species 
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The vitamin K content of food of animal and plant origin compiled from European data (Souci et al., 
2008), based on phylloquinone measurement, confirmed the results of earlier studies (Schurgers and 
Vermeer, 2000; Damon et al., 2005) that vegetables, and especially green leafy vegetables, contain 
much higher quantities of phylloquinone than animal products (by a factor 5 to 100). Among foods of 
animal origin, very low levels were found in cow milk (3.0–4.4 µg/L) and in increasing order in fish 
flesh (26–400 µg/kg), whole egg (19–500 µg/kg), meat (130–180 µg/kg) and liver (560–890 µg/kg). A 
study of the vitamin K contents of food in The Netherlands considered separately phylloquinone, MK-
4 and higher MK-n, using a high-performance liquid chromatography (HPLC method) (Schurgers and 
Vermeer, 2000). It appeared that MK-4 was present in all animal tissues tested (meat, dairy products 
and eggs), but the lack of substantial differences between wild (hare, deer), free-range and intensively 
raised animals suggests that the conversion and subsequent retention of menadione from supplemented 
feed does not contribute substantially to MK-4 concentration in tissues. The authors concluded that the 
major part of MK-4 in animal tissues is likely to originate from the conversion of phylloquinone, as 
already shown to occur in the rat (Thijssen et al., 1996, 2006); on the basis of food questionnaires and 
data collected, these authors calculated that phylloquinone represents almost 90 % of the total dietary 
vitamin K intake in the Dutch population, whereas menaquinones account for less than 12 %.  
3.4.3.  Conclusions on safety for the consumer  
Since vitamin K supplementation of feedingstuffs as MSB and MNB is in widespread routine use, the 
FEEDAP  Panel  considers  that  above-mentioned  population  exposure  figures  already  include  the 
contribution of edible tissues and products of animals fed vitamin K-supplemented diets. Moreover, 
MSB and MNB administration to farmed animals generates MK-4 residues which represent only a 
small fraction of total vitamin K active compounds in animal tissues. Therefore, the FEEDAP Panel 
considers that the use of MSB and MNB in animal nutrition does not give rise to safety concerns for 
consumers. 
3.5.  Safety for the user 
3.5.1.  Effects on respiratory system 
The moderate to high dusting potential and the high proportion of particles of diameter < 50 µm 
indicate a potential for inhalation of MSB and MNB. Since no data on inhalation toxicity of MSB and 
MNB have been provided, inhalation of dust is considered as potentially hazardous. 
The FEEDAP Panel assessed the user exposure resulting from the residual content of chromium in 
MSB. Since sodium dichromate (Na2Cr2O7) is used as catalyst in the manufacture of the additive (see 
section 2.1.1), and in the absence of more detailed information on the chromium species in MSB, it is 
plausible that all residual chromium would be Cr(VI), i.e. the most toxic species and a recognised 
human carcinogen. 
Using the highest values as a worst-case assumption (dusting potential up to 15.4 g/m
3, chromium 
content  in  the  dust  up  to  182 mg/kg),  the  chromium  concentration  in  the  air  would  be  up  to 
2 801 µg Cr/m
3 for MSB. As for MNB, a worst-case calculation based on the highest values (dusting 
potential  up  to  0.46 g/m
3,  chromium  content  in  the  dust  up  to  71 mg/kg)  provides  a  chromium 
concentration in the air of 32.7 µg/m
3.  
The calculated values for both MSB and MNB are above the threshold limit value set by ACGIH 
(2004;  10 µg/m
3  threshold  limit  value  (TLV)  time-weighted  average  (TWA),  insoluble  Cr(VI) 
compounds), the action level set by OSHA (2009; 2.5 µg Cr(VI)/m
3 for an eight-hour TWA exposure) 
and the more recent NIOSH (2013) recommended exposure limit (0.2 µg Cr(VI)/m
3 for an eight-hour 
TWA exposure, 40-hour working week). In particular, the worst-case calculation for MSB would 
greatly  exceed  the  ACGIH,  OSHA  and  NIOSH  parameters  by  factors  of  280,  1 120  and  14 000 
respectively, whereas that for MNB would exceed these parameters by factors of 3, 13 and 164, 
respectively.  Vitamin K3 for all animal species 
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The FEEDAP Panel recognises that the scenarios used for setting occupational exposure limits depict 
a  more  prolonged  and  continuous  exposure  than  expected  from  occupational  handling  of  feed 
additives. However, considering the magnitude by which these thresholds are exceeded, the FEEDAP 
concludes that the content of chromium in both MSB and MNB gives rise to a concern for users‘ 
safety. 
3.5.2.  Effects on the eyes and skin 
Skin and eye irritation tests with MSB were performed in accordance with the appropriate OECD 
guidelines.
36 
In the skin irritation test, 500 mg MSB was applied in single dose to intact skin of three albino rabbits 
for a period of four hours. No significant signs of irritation were detected. 
In the eye irritation test,  the conjunctival sac of  three albino male rabbits  was instilled with 100 mg 
MSB. There were no effects on the cornea and the iris, but the conjunctivae showed severe congestion 
and chemosis. The congestion regressed in all treated animals  seven days after the treatment and 
chemosis regressed 72 hours after the treatment. MSB should be considered as an eye irritant.  
Since no data on skin or eye irritation of MNB are available, it would be prudent to consider MNB as 
an irritant to skin and eye. 
No skin sensitisation tests are available on either MSB  or MNB. A single case of contact dermatitis 
upon occupational exposure to airborne MSB when mixing additives in feeds has been  reported.
36 
Both substances should be regarded as potential skin sensitisers. 
Cr(VI) is recognised as dermatologically toxic, inducing sensitisation and allergic contact dermatitis 
after repeated exposures to levels lower than those present in the additives (Shelnutt et al., 2007; Geier 
et al., 2011). Potassium dichromate was found to be the most frequent allergen among 20 common 
allergens  (Geier  et  al.,  2011).  Exposure  by  inhalation  to  Cr(VI)  dust  exacerbates  allergic  asthma 
(Schneider et al., 2012). Owing to the presence of Cr(VI), the possibility of allergic reactions cannot 
be ruled out. 
3.5.3.  Conclusions on user safety 
MSB is as an eye irritant; in the absence of adequate data, the additive should be considered as a skin 
sensitiser. 
In the absence of data, MNB should be considered as irritant to skin and eyes and as a skin sensitiser. 
Considering the high dusting potential of MSB and MNB, the absence of data on inhalation toxicity 
and chromium(VI) content of the dust, the FEEDAP Panel concludes that inhalation exposure from 
handling of MSB and MNB could be hazardous.  
3.6.  Safety for the environment 
Vitamin K occurs widely in nature as phylloquinone in plants. Phylloquinone from feed materials, as 
well as MSB and MNB used as feed additives, is excreted mainly as menaquinones in faeces and as 
menadione  in  small  amounts  in  urine.  Thus,  the  natural  plant  vitamin  K  and  the  chemically 
synthesised K3 compound add to the same pool of substances in the environment. Considering the 
huge amount of phylloquinone in nature, the use of MSB and MNB in animal nutrition is not expected 
to substantially increase the concentration of vitamin K metabolites in the environment. Therefore, no 
risk to the environment resulting from the use of MSB and MNB in animal nutrition is expected. 
                                                       
36 Technical dossier/Section III/Reference 3.3.02. Vitamin K3 for all animal species 
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4.  Efficacy 
According  to  Regulation  (EC)  No  429/2008,  efficacy  studies  are  not  required  for  vitamins,  pro-
vitamins and chemically well-defined substances having similar effects which are already authorised 
as feed additives. Owing to the long history of use and its established nutritional role in domestic 
animals, MSB and MNB are regarded as effective sources of the vitamin K. Vitamin K has been 
globally used in animal nutrition for decades. Data on requirement, allowances and recommendations 
for feed supplementation are easily accessible as standard literature for animal nutrition.  
One milligram of vitamin K3 is defined as 1 mg menadione. Equivalent doses of MSB and MNB 
would be 2.00 and 2.27 mg, respectively. 
The FEEDAP Panel notes that MNB is also a source of nicotinamide. The efficacy of nicotinamide as 
a  feed  additive  for  all  animal  species  has  recently  been  assessed  by  the  FEEDAP  Panel  (EFSA 
FEEDAP Panel, 2012). 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
37  and  by  good 
manufacturing practice. 
CONCLUSIONS AND RECOMMENDATIONS 
CONCLUSIONS 
Acute toxicity of menadione or its derivatives is reached at levels exceeding the requirements by a 
factor of at least 1 000. MSB and MNB are safe for all animal species at practical use levels in feed. 
The use of MSB in water for drinking is likely to increase the exposure of target animals to Cr(VI). 
Therefore, the FEEDAP Panel has concerns about the safety of MSN when administered by this route. 
The use of MSB and MNB in animal nutrition does not give rise to concerns for consumers. 
MSB is as an eye irritant; in the absence of adequate data, the additive should be considered as a skin 
sensitiser. In the absence of data, MNB should be considered as irritant to skin and eyes and as a skin 
sensitiser. Considering the high dusting potential of MSB and MNB, the absence of data on inhalation 
toxicity and the chromium (VI) content of dust, inhalation exposure from handling of MSB and MNB 
could be hazardous. 
The use of MSB and MNB in animal nutrition does not pose a risk to the environment. 
MSB and MNB are regarded as effective sources of vitamin K in animal nutrition. 
RECOMMENDATIONS 
The substances under application should be listed as vitamin K3 (not as vitamin K). Vitamin K3 is 
equivalent to menadione; 1 mg vitamin K3 would be equivalent to 2.00 mg MSB and 2.27 mg MNB. 
When labelled, the active substances should be labelled as MSB or MNB. 
Considering  the  content  of  non-speciated  chromium  in  MSB  and  MNB,  the  FEEDAP  Panel 
recommends that the chromium content of all production batches be monitored and that the content of 
hexavalent chromium be reduced as much as possible. 
Vitamin mineral premixtures containing MSB should not be stored for longer than one month. 
                                                       
37   Regulation  (EC)  No  183/2005  of  the  European  Parliament  and  of  the  Council  of  12  January  2005  laying  down 
requirements for feed hygiene. OJ L 35, 8.2.2005, p. 1. Vitamin K3 for all animal species 
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Considering the potential hazard to users by inhalation, the FEEDAP Panel strongly recommends that 
the use of the additives MSB and MNB be restricted to premixture manufacturers. 
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APPENDIX 
Executive Summary of the Evaluation Report of the European Union Reference Laboratory for 
Feed Additives on the Method(s) of Analysis for Vitamin K3 (Menadione)
38 
In  the  current  application  authorisation  is  sought  for  Vitamin  K3  (Menadione)  under  the 
category/functional  group  3(a)  ‗nutritional  additives‘/‗vitamins,  pro-vitamins  and  chemically  well 
defined substances having similar effect‘ according to Annex I of Regulation (EC) No 1831/2003. 
Specifically, authorisation is sought to use the active substances, Menadione Sodium Bisulphite (MSB) 
and Menadione Nicotinamide Bisulphite (MNB) for all animal species and categories, with a minimum 
content of 50 % and 44 % of Menadione, respectively. The feed additive is intended to be incorporated 
in feedingstuffs through premixtures or directly in water (only for MSB). However, the Applicant did 
not specify any maximum or minimum concentration of MSB and MNB in feedingstuffs or water. 
For  the  determination  of  Vitamin  K3  (Menadione)  and  its  commercial  derivatives 
Menadione  Sodium  Bisulphite  (MSB)  and  Menadione  Nicotinamide  Bisulphite  (MNB)  in  the  feed 
additive the Applicant proposed a Method from the Association of German Agricultural Analytical 
Research Institutes (VDLUFA), validated for premixtures and feedingstuffs. The Applicant applied 
this method to the feed additive and reported a relative standard deviation of repeatability (RSDr) of 
1.7 % for MSB and MNB containing 50 % and 44 % of Menadione, respectively. Moreover, a recovery 
rate (RRec) ranging from 101 % to 104 % was calculated by EURL, based on the experimental data 
provided by Applicant. 
Based on the performance characteristic presented, the EURL recommends for official control the 
validated method from VDLUFA (Bd.III 13.7.1) to determine Vitamin K3 in the feed additive. 
For the determination of Vitamin K3 in premixtures and feedingstuffs the Applicant proposed the above 
mentioned VDLUFA method - validated for premixtures and feedingstuffs, for which an RSDr ranging 
from 10 % to 20 % is reported. 
An  alternative  ring-trial  validated  method  for  premixtures  and  feedingstuffs  was  published  in  the 
Italian  Official  Journal,  based  on  Normal  Phase  High-Performance  Liquid  Chromatography  (NP-
HPLC)  coupled  to  Ultraviolet  (UV)  detector,  using  a  wavelength  of  251 nm.  The  following 
performance characteristics were reported for premixtures, complementary feedingstuffs and complete 
feedingstuffs samples with a Vitamin K3 (Menadione) content ranging from 5.57 to 543 mg/kg:  
- RSDr ranging from of 2.9 to 6.8 % ; 
- a relative standard deviation of reproducibility (RSDR) ranging from 7.0 to 11.7%; 
- RRec ranging from 89.2 to 111.4 %, and 
- a limit of detection (LOD) and quantification (LOQ) of 1.2 and 3.8 mg/kg, respectively. 
Based on the performance characteristics presented, the EURL recommends for official control the 
ring-trial validated method, published in the Italian Official Journal, based on Normal Phase High-
Performance Liquid Chromatography (NP-HPLC) coupled to UV detector to determine Vitamin K3 in 
premixtures and feedingstuffs, within the concentration range covered. 
For the determination of the Menadione Sodium Bisulphite (MSB) in water, the Applicant applied the 
VDLUFA method. The following performances characteristics were reported for a concentration of 
0.5 g Menadione /L: 
                                                       
38 The full report is available on the EURL website. http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2010-0099.pdf 
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- RSDr ranging from 1.8 to 4.4 %, and 
- RRec ranging from 97.9 to 99.2 %. 
Based on the performance characteristics presented, the EURL recommends for official control the 
validated method from VDLUFA (Bd.III 13.7.1) to determine Vitamin K3 in water. 
Further  testing  or  validation  of  the  methods to  be performed  through  the consortium  of  National 
Reference Laboratories as specified by article 10 (Commission Regulation (EC) No 378/2005) is not 
considered necessary.  